New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
14:02 EDTHUM, AMEDAmedisys sinks after warning new deal will generate less revenue
Home health care provider Amedisys (AMED) is tumbling after the company renewed its contract with health insurer Humana (HUM), but predicted that the new deal would generate 50% less revenue than the previous agreement. The new contract may cover fewer markets and Amedisys will be paid on a per visit basis, rather than on an episodic basis as was previously the case, Amedisys reported. Amedisys, which noted that it had previously generated $65M-$70M in revenue from Humana each year, said the new agreement would begin impacting its revenue this quarter. However, the "full impact" of the deal won't be felt until 2013, the home health care provider added. In mid-afternoon trading, Amedisys sank $1.39, or 10.43%, to $11.94.
News For AMED;HUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 16, 2015
10:47 EDTHUMBofA/Merrill healthcare facilities analyst analyst/industry conference call
Healthcare Facilities & Managed Care Analyst Bressler discusses the legislative and regulatory outlook for the industry for 2015 on an Analyst/Industry conference call to be held on January 23 at 2 pm.
January 15, 2015
13:47 EDTAMEDAmedisys sees '15 impact from Medicare Home Health rule more moderate
Amedisys announced that it expects the impact of the 2015 Medicare Home Health Prospective Payment System Final Rule to be more moderate than previously anticipated. Previously, the company had disclosed that it expected an impact of -0.80% relative to 2014 Medicare pricing; however, after further analysis, the company now expects the 2015 pricing to be relatively unchanged from 2014.
January 14, 2015
10:33 EDTAMEDAmedisys targets market share capture in home health in 2015
The company says hospice growth will be key as it seeks to reverse ADC declines in 2015. Targets incremental efficiencies in cost of revenue and field and corporate G&A. Comments taken from slides for January Investor Presentation.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use